Aardvark Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Sun Nelson | Chief Financial Officer | Purchase | 3,000 | $14.40 | $43,200 | 108,484 | Dec 11, 2025 |
| Lee Tien-Li | Chief Executive Officer | Purchase | 7,000 | $14.49 | $101,430 | 1,551,613 | Dec 11, 2025 |
| Lee Tien-Li | Chief Executive Officer | Option Exercise | 1,229 | $4.24 | $5,211 | 1,544,613 | Oct 15, 2025 |
| Jones Bryan | Chief Operating Officer | Option Exercise | 1,250 | $4.24 | $5,300 | 1,250 | Oct 15, 2025 |
| Lee Tien-Li | Chief Executive Officer | Purchase | 3,500 | $9.94 | $34,790 | 1,543,384 | Sep 15, 2025 |
| Lee Tien-Li | Chief Executive Officer | Purchase | 5,000 | $8.50 | $42,500 | 1,533,384 | Sep 11, 2025 |
| Sun Nelson | Chief Financial Officer | Purchase | 6,000 | $8.07 | $48,420 | 105,484 | Sep 9, 2025 |
| Lee Tien-Li | Chief Executive Officer | Option Exercise | 17,209 | $4.24 | $72,966 | 1,513,384 | Aug 28, 2025 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | — | C | 333,412 | — | — | 333,412 | Feb 14, 2025 |
| Chi Jeffrey | — | C | 133,364 | — | — | 133,364 | Feb 14, 2025 |
| Vickers Venture Fund VI Pte Ltd | — | C | 413,491 | — | — | 2,050,902 | Feb 14, 2025 |
| Lee Tien-Li | Chief Executive Officer | C | 41,303 | — | — | 1,479,633 | Feb 14, 2025 |
| Sun Nelson | Chief Financial Officer | C | 7,001 | — | — | 89,484 | Feb 14, 2025 |
| Chen Bihua | — | C | 800,189 | — | — | 800,189 | Feb 14, 2025 |